AMICUS THERAPEUTICS INC's ticker is FOLD and the CUSIP is 03152W109. A total of 225 filers reported holding AMICUS THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is 0.58 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $358 | +18.5% | 32,307 | +30.7% | 0.03% | +10.0% |
| Q4 2022 | $302 | -99.9% | 24,711 | -28.6% | 0.03% | -16.7% |
| Q3 2022 | $361,000 | -47.7% | 34,620 | -52.1% | 0.04% | -56.6% |
| Q3 2021 | $690,000 | +165.4% | 72,282 | +170.9% | 0.08% | +97.6% |
| Q4 2019 | $260,000 | -10.0% | 26,680 | -26.0% | 0.04% | -17.6% |
| Q3 2019 | $289,000 | -7.1% | 36,061 | +44.5% | 0.05% | -1.9% |
| Q2 2019 | $311,000 | +80.8% | 24,948 | +75.0% | 0.05% | +116.7% |
| Q3 2018 | $172,000 | +59.3% | 14,256 | -28.2% | 0.02% | -17.2% |
| Q2 2016 | $108,000 | – | 19,842 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 10,524,022 | $127,972,108 | 12.11% |
| Perceptive Advisors | 27,692,917 | $336,745,870 | 11.23% |
| Redmile Group, LLC | 16,944,621 | $206,046,591 | 9.80% |
| Finepoint Capital LP | 1,489,025 | $18,106,544 | 9.02% |
| CM Management, LLC | 450,000 | $5,472,000 | 5.81% |
| Avoro Capital Advisors LLC | 27,400,000 | $333,184,000 | 5.20% |
| MPM BioImpact LLC | 716,139 | $8,708,250 | 2.32% |
| Artal Group S.A. | 4,062,567 | $49,401 | 2.12% |
| SECTORAL ASSET MANAGEMENT INC | 803,464 | $9,770,122 | 1.90% |
| GREAT POINT PARTNERS LLC | 857,000 | $10,421,120 | 1.90% |